Immune-epidemiological parameters of the novel coronavirus–a perspective

A Saghazadeh, N Rezaei - Expert review of clinical immunology, 2020 - Taylor & Francis
Introduction At the end of 2019, Wuhan, a city in China with a population of about 11 million,
witnessed the outbreak of unusual pneumonia. As of 29 March 2020, the disease has …

The role of dysregulated immune responses in COVID-19 pathogenesis

S Tahaghoghi-Hajghorbani, P Zafari, E Masoumi… - Virus research, 2020 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19) which caused by severe acute
respiratory syndrome-related coronavirus (SARS-CoV-2), is a pandemic threat to global …

[PDF][PDF] The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID—19 Infections among Healthy Adults, Elderly and Children. Electron J …

AS Abdulamir, RR Hafidh - 2020 - pdfs.semanticscholar.org
Accepted: 19 Mar. 2020 Novel Coronavirus, COVID-19 discovered in December, 2019 in
Wuhan, China started a world-wide epidemic. It is not clear till now what is the pathogenesis …

[HTML][HTML] Immune response, inflammation, and the clinical spectrum of COVID-19

LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …

[HTML][HTML] Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm

S Mahmoudi, M Rezaei, N Mansouri, M Marjani… - Journal of clinical …, 2020 - Springer
To the Editor: Since the emergence of Coronavirus Disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …

[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–Current perspectives

JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …

Immune response in COVID-19: What do we currently know?

DS Oliveira, NI Medeiros, JAS Gomes - Microbial pathogenesis, 2020 - Elsevier
In 2002/2003 there was a pandemic denominate SARS (severe acute respiratory
syndrome), caused by the SARS-CoV virus that belongs to the genera Betacoranavirus and …

[HTML][HTML] The immune response and immunopathology of COVID-19

E Mortaz, P Tabarsi, M Varahram, G Folkerts… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses were first discovered in the 1960s and are named due to their crown-like
shape. Sometimes, but not often, a coronavirus can infect both animals and humans. An …

[HTML][HTML] COVID-19: immunopathology and its implications for therapy

X Cao - Nature reviews immunology, 2020 - nature.com
Severe coronavirus disease 2019 (COVID-19) is characterized by pneumonia, lymphopenia,
exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; …

[HTML][HTML] Immune parameters and COVID-19 infection–associations with clinical severity and disease prognosis

M Jesenak, M Brndiarova, I Urbancikova… - Frontiers in cellular …, 2020 - frontiersin.org
Severe acute respiratory syndrome caused by a novel 2019 coronavirus (SARS-CoV2)
represents one of the most studied infectious diseases of today. The number of scientific …